Dr. Patricia H. Hardenbergh
Claim this profileShaw Cancer Center
Studies Breast Cancer
Studies Cancer
10 reported clinical trials
40 drugs studied
Area of expertise
1Breast Cancer
HER2 positive
Stage II
Stage I
2Cancer
p16 negative
EGFR positive
EGFR negative
Affiliated Hospitals
Clinical Trials Patricia H. Hardenbergh is currently running
Standard Therapy + Surgery/Radiation
for Prostate Cancer
This phase III trial studies how well standard systemic therapy with or without definitive treatment (prostate removal surgery or radiation therapy) works in treating participants with prostate cancer that has spread to other places in the body. Addition of prostate removal surgery or radiation therapy to standard systemic therapy for prostate cancer may lower the chance of the cancer growing or spreading.
Recruiting2 awards Phase 330 criteria
Chemotherapy + Radiation Therapy
for Head and Neck Cancer
This phase II/III trial studies how well radiation therapy works when given together with cisplatin, docetaxel, cetuximab, and/or atezolizumab after surgery in treating patients with high-risk stage III-IV head and neck cancer the begins in the thin, flat cells (squamous cell). Specialized radiation therapy that delivers a high dose of radiation directly to the tumor may kill more tumor cells and cause less damage to normal tissue. Drugs used in chemotherapy, such as cisplatin and docetaxel, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. Cetuximab is a monoclonal antibody that may interfere with the ability of tumor cells to grow and spread. Immunotherapy with monoclonal antibodies, such as atezolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. The purpose of this study is to compare the usual treatment (radiation therapy with cisplatin chemotherapy) to using radiation therapy with docetaxel and cetuximab chemotherapy, and using the usual treatment plus an immunotherapy drug, atezolizumab.
Recruiting1 award Phase 2 & 321 criteria
More about Patricia H. Hardenbergh
Clinical Trial Related6 years of experience running clinical trials · Led 10 trials as a Principal Investigator · 4 Active Clinical TrialsTreatments Patricia H. Hardenbergh has experience with
- Radiation Therapy
- Atezolizumab
- Cisplatin
- Triptorelin
- Bicalutamide
- Degarelix
Breakdown of trials Patricia H. Hardenbergh has run
Breast Cancer
Cancer
Prostate Cancer
Ductal Carcinoma
Bladder Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Patricia H. Hardenbergh specialize in?
Patricia H. Hardenbergh focuses on Breast Cancer and Cancer. In particular, much of their work with Breast Cancer has involved HER2 positive patients, or patients who are Stage II.
Is Patricia H. Hardenbergh currently recruiting for clinical trials?
Yes, Patricia H. Hardenbergh is currently recruiting for 4 clinical trials in Edwards Colorado. If you're interested in participating, you should apply.
Are there any treatments that Patricia H. Hardenbergh has studied deeply?
Yes, Patricia H. Hardenbergh has studied treatments such as Radiation Therapy, Atezolizumab, Cisplatin.
What is the best way to schedule an appointment with Patricia H. Hardenbergh?
Apply for one of the trials that Patricia H. Hardenbergh is conducting.
What is the office address of Patricia H. Hardenbergh?
The office of Patricia H. Hardenbergh is located at: Shaw Cancer Center, Edwards, Colorado 81632 United States. This is the address for their practice at the Shaw Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.